These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17913866)

  • 21. Genital ulcers and concomitant complaints in men attending a sexually transmitted infections clinic: implications for sexually transmitted infections management.
    O'Farrell N; Morison L; Moodley P; Pillay K; Vanmali T; Quigley M; Sturm AW
    Sex Transm Dis; 2008 Jun; 35(6):545-9. PubMed ID: 18356769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
    Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China.
    Ngo TD; Laeyendecker O; Morrow RA; Lai S; Quinn TC
    Clin Vaccine Immunol; 2008 Aug; 15(8):1301-3. PubMed ID: 18508932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory.
    Turner KR; Wong EH; Kent CK; Klausner JD
    Sex Transm Dis; 2002 Jul; 29(7):422-5. PubMed ID: 12170133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics.
    Singh AE; Romanowski B; Wong T; Gourishankar S; Myziuk L; Fenton J; Preiksaitis JK
    Sex Transm Dis; 2005 Feb; 32(2):95-100. PubMed ID: 15668615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.
    Laeyendecker O; Henson C; Gray RH; Nguyen RH; Horne BJ; Wawer MJ; Serwadda D; Kiwanuka N; Morrow RA; Hogrefe W; Quinn TC
    J Clin Microbiol; 2004 Apr; 42(4):1794-6. PubMed ID: 15071053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
    Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
    Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India.
    Risbud A; Chan-Tack K; Gadkari D; Gangakhedkar RR; Shepherd ME; Bollinger R; Mehendale S; Gaydos C; Divekar A; Rompalo A; Quinn TC
    Sex Transm Dis; 1999 Jan; 26(1):55-62. PubMed ID: 9918324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.
    Eing BR; Lippelt L; Lorentzen EU; Hafezi W; Schlumberger W; Steinhagen K; Kühn JE
    J Clin Microbiol; 2002 Feb; 40(2):407-13. PubMed ID: 11825950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
    Suligoi B; Calistri A; Cusini M; Palù G;
    J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of HSV-2 type specific serological tests in men in Kenya.
    Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
    J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.
    van Dyck E; Buvé A; Weiss HA; Glynn JR; Brown DW; De Deken B; Parry J; Hayes RJ
    J Clin Microbiol; 2004 Jul; 42(7):2961-5. PubMed ID: 15243045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.
    Görander S; Mbwana J; Lyamuya E; Lagergård T; Liljeqvist JA
    Clin Vaccine Immunol; 2006 Jun; 13(6):633-9. PubMed ID: 16760320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies.
    Reddy SM; Balakrishnan P; Uma S; Thyagarajan SP; Solomon S
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):359-60. PubMed ID: 15699434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil.
    Carvalho M; de Carvalho S; Pannuti CS; Sumita LM; de Souza VA
    Int J Infect Dis; 1998-1999 Winter; 3(2):94-8. PubMed ID: 10225987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study.
    Perez G; Skurnick JH; Denny TN; Stephens R; Kennedy CA; Regivick N; Nahmias A; Lee FK; Lo SC; Wang RY; Weiss SH; Louria DB
    Int J Infect Dis; 1998; 3(1):5-11. PubMed ID: 9831669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of herpes simplex virus-1 and -2 in attendees of a sexually transmitted infection clinic in Singapore.
    Theng CT; Sen PR; Chio TW; Tan HH; Wong ML; Chan RK
    Sex Health; 2006 Dec; 3(4):269-74. PubMed ID: 17112439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
    van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
    Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population.
    Wagner HU; Van Dyck E; Roggen E; Nunn AJ; Kamali A; Schmid DS; Dobbins JG; Mulder DW
    Int J STD AIDS; 1994; 5(5):332-7. PubMed ID: 7819350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
    Slomka MJ
    Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.